Pretreatment with LCK inhibitors chemosensitizes cisplatin‐resistant endometrioid ovarian tumors
Abstract Background Ovarian cancer is the most fatal gynecologic malignancy in the United States. While chemotherapy is effective in the vast majority of ovarian cancer patients, recurrence and resistance to standard systemic therapy is nearly inevitable. We discovered that activation of the non-rec...
Saved in:
Main Authors: | Katie K. Crean-Tate (Author), Chad Braley (Author), Goutam Dey (Author), Emily Esakov (Author), Caner Saygin (Author), Alexandria Trestan (Author), Daniel J. Silver (Author), Soumya M. Turaga (Author), Elizabeth V. Connor (Author), Robert DeBernardo (Author), Chad M. Michener (Author), Peter G. Rose (Author), Justin Lathia (Author), Ofer Reizes (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer
by: Goutam Dey, et al.
Published: (2023) -
Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer
by: Elizabeth V. Connor, et al.
Published: (2019) -
c-CBL/LCK/c-JUN/ETS1/CD28 axis restrains childhood asthma by suppressing Th2 differentiation
by: Nan Yang, et al.
Published: (2024) -
Efficacy of hyperthermic intraperitoneal chemotherapy and interval debulking surgery in women with advanced uterine serous carcinoma
by: Laura M. Chambers, et al.
Published: (2021) -
Bladder Cancer Chemosensitivity Is Affected by Paraoxonase-2 Expression
by: Stefania Fumarola, et al.
Published: (2020)